StarD10 is a dual specificity lipid transfer
StarD10 is a dual specificity lipid transfer protein capable of shuttling phosphatidylcholine and phosphatidylethanolamine between membranes in vitro. We now provide evidence that, in vivo, StarD10 is phosphorylated on serine 284. This novel phosphorylation site was identified by tandem mass spectrometry of immunoaffinitypurified StarD10 from lysates of HEK293T cells transiently expressing the protein. In vitro kinase assays revealed that casein kinase II (CKII) was capable of phosphorylating wild type StarD10 but not a S284A mutant protein. Interestingly, hypotonic extracts prepared from HEK293T cells expressing the serine to alanine mutant exhibited increased lipid transfer activity compared with those from wild type StarD10 expressing cells, suggesting that, in a cellular context, phosphorylation on serine 284 negatively regulates StarD10 activity. Since CKII phosphorylation also inhibited lipid transfer activity of the purified recombinant StarD10 protein, inhibition is not dependent on any cellular cofactors. Instead, our data show that carboxy-terminal StarD10 phosphorylation on serine 284 regulates its association with cellular membranes.
Lipids are essential for the structural and functional integrity of cells. As the predominant constituent of cellular membranes, lipids compartmentalize cellular functions, are critical for protein sorting, and are involved in various aspects of signal transduction. Lipids are differentially distributed both between and within membranes in the cell. This differential distribution of lipids is achieved in part by regulated transport of lipids (1;2). Phospholipids are predominantly synthesized in the endoplasmatic reticulum (ER) and subsequently transported to various destinations by vesicular transport. Lipids can also be delivered to specific cellular organelles by monomeric exchange. This non-vesicular lipid trafficking can be highly efficient and requires desorption of the lipid from the donor membrane, passage through the aqueous phase and subsequent insertion into the acceptor membrane. Spontaneous release from the membrane into the aqueous phase is a rare event for phospholipids carrying two long acyl chains. Several cytosolic proteins with specific lipid binding domains capable of accelerating lipid exchange in vitro have been identified. These proteins include phosphatidylinositol transfer proteins (PITPs), sterol carrier protein 2, and members of the steroidogenic acute regulatory protein (StAR)-related lipid transfer (START) domain family (3) .
START domains have been identified in 15 mammalian proteins, which have been assigned the formal names StarD1-15, and are also found in plants, worms, flies, fish, and bacteria (4;5) . START domains are approximately 210 amino acids in length and form a hydrophobic tunnel that accommodates a monomeric lipid. The founding member of the START family, StAR/StarD1, is essential for cholesterol transport to the inner mitochondrial membrane, where the conversion of cholesterol to pregnenolone takes place (6) . Phosphatidylcholine transfer protein (Pctp/StarD2), on the other hand, is known to bind and transfer phosphatidylcholine (PC) between membranes, but no other phospholipids or sterols. The StarD2 subfamily of START proteins further comprises Cert/StarD11, StarD10 and StarD7. CERT was identified to catalyze the non-vesicular transport of ceramide from the ER to the Golgi (7). To fulfil its ceramide carrier function CERT contains two membrane-targeting domains: one for ER and another for Golgi targeting (7;8). The protein is thought to either shuttle between the two organelles or act directly between closely opposed donor and acceptor membranes at so-called membrane contact sites (9;10). Opposed to CERT, little is known about the physiological function of Pctp, StarD10, and StarD7. Based on the enrichment of Pctp in liver and the observation that activity in vitro is stimulated by bile salts, it has been postulated that Pctp functions in the delivery of PC from its principal site of synthesis in the ER to hepatocyte canalicular membranes for secretion into bile. However, mice carrying a deletion in the gene encoding Pctp were phenotypically normal (11) . This may be due to functional redundancy with StarD10, which is also expressed in liver and possesses lipid transfer activity for PC and, to a lesser extent, phosphatidylethanolamine (PE).
We have previously shown by electron spin resonance measurement of spin-labeled lipids and using fluorescently labeled lipids analogs incorporated into liposomes that recombinant StarD10 interacts with phospholipids in solution and in membranes. Incubation of StarD10 with liposomes prepared with radiolabeled cellular lipids demonstrated that StarD10 also binds endogenous PC and PE. StarD10 was further shown to bind lipids in vivo by crosslinking of protein expressed in transfected HEK293T cells with photoactivable PC (12) . The molecular mechanisms, however, that control StarD10 lipid binding and transfer activity are still unknown. Opposed to CERT, StarD10 lacks specific targeting motifs and potential donor and acceptor membranes within the cell still remain elusive. Here we present data that sheds light onto the in vivo regulation of StarD10. StarD10 is phosphorylated by CKII on serine 284, whereby lipid transfer activity and membrane association are inhibited. Carboxyterminal phosphorylation thus appears to represent an efficient means to regulate StarD10 activity.
EXPERIMENTAL PROCEDURES
Reagents and antibodies − Porcine brain lipids (total extract) were purchased from Avanti Polar Lipids (Alabaster, AL), pyrene-labeled phospholipids 1-hexadecanoyl-1-(1-pyrenedecanoyl)-sn-glycero-3-phosphocholine (pyrene-PC) and -phosphoethanolamine (pyrene-PE) were from Molecular Probes (Leiden, The Netherlands), 2,4,6-trinitro-phenyl-PE (TNP-PE), kindly provided by P. Somerharju (University of Helsinki), was prepared as described (13) . Antibodies used were: mouse anti-Flag and anti-α-tubulin monoclonal antibodies (Sigma-Aldrich), mouse anti-transferrin receptor monoclonal antibody (Invitrogen). Peroxidase-labeled secondary anti-mouse and anti-rabbit IgG antibodies were from Amersham; alkaline phosphatase-labeled secondary anti-mouse IgG antibody was from Sigma.
Cell culture, expression constructs and transfection − HEK293T cells were grown in RPMI supplemented with 10% fetal calf serum (FCS) in a humified atmosphere containing 5% CO 2 . Cells were transfected using TransIT293 reagent (Mirus) according to the manufacturer's instructions. The cloning of pEFrPGKpuro-FlagStarD10 has been described previously (14) . The full-length StarD10 cDNA was subcloned into the pEGFPC1 vector (Invitrogen). The cDNA encoding StarD10-Δ8 was generated by PCR amplification and point mutants of StarD10 were generated by Quikchange site-directed PCR mutagenesis following the manufacturer's instructions (Stratagene) and verified by sequencing.
Immunoaffinity purification of StarD10, 2D PAGE and mass spectrometry − HEK293T cells transiently expressing Flag-tagged StarD10 were lysed in NEB [50 mM Tris (pH 7.5), 150 mM NaCl, 1% NP40, 1 mM sodium orthovanadate, 10 mM sodium fluoride, and 20 mM β-glycerophosphate plus Complete protease inhibitors (Roche)] and lysates were clarified by centrifugation before passing over anti-Flag M2 immunoaffinity resin (Sigma). The resin was washed with NEB, followed by washes with phosphate buffered saline (PBS). Flag-StarD10 was eluted with 100 mM glycine, pH 2.5, and fractions were neutralized with 1/10 volume of 1 M Tris, pH 8. Fractions containing StarD10 as determined by Western blotting with anti-Flag antibody were pooled and concentrated by ultrafiltration using Amicon Ultra-4 columns (10000 NMWL, Millipore). The concentrated samples was subjected to two-dimensional SDS-PAGE and stained with Coomassie Phast Blue as described (15) . For MS analysis, the protein was subjected to one-dimensional SDS-PAGE and the band corresponding to StarD10 was excised from the gel and destained with 50 mM NH 4 HCO 3 /acetonitrile (1:1 by vol.). Cysteines were first reduced with 1,4-dithio-DL-threitol and then alkylated with iodacetamide. The protein was ingel digested with modified porcine trypsin, the digest was stopped with formic acid and peptides were extracted with 50 µl 25 mM NH HCO for 30 min in an ultrasonic bath. The supernatant was recovered and extraction was repeated with 50 µl acteonitrile, followed by 50 µl 5% formic acid and, finally, 50 µl acetonitrile. All supernatants were combined, vacuum-dried and resuspended in 4 3 10 μl 5% formic acid. Phosphopeptides were enriched with the SwellGel ® Gallium-Chelated Disc (Phosphopeptide Isolation Kit, Pierce, Rockford, IL, USA) according to the manufacturer's recommendations. Eluates were vacuum-concentrated and resuspended in 10 μl 5% formic acid. The sample was then desalted on a Zip Tip ® μ-C18 (Millipore, Bedford, MA, USA) and eluted stepwise into nano-spray capillaries (MDS Proteomics, Odense, Denmark) with 20%, 40%, and 60% aqueous methanol containing 5% formic acid. A QSTAR Pulsar i quadrupole time of flight (TOF) mass spectrometer (Applied Biosystem, MDS Sciex, Toronto, Canada) equipped with a nano-electrospray ion source (MDS Proteomics, Odense, Denmark) was used. TOF-MS spectra were collected in the "enhance all" modus and charged ions of peptides were chosen manually for product ion analysis. Product ion spectra (tandem MS) were acquired with collision energies optimized for each peptide to obtain an effective fragmentation pattern with 10% intensity of the residual precursor ion. Argon was used as collision gas at a recorded pressure of 4.3 x 10 -5 Torr. Data were searched by the tandem mass spectrum database matching tool Mascot (http://www.matrixscience.com). The NCBInr and SwissProt databases were searched with the variable modifications deamidation, oxidation of methionine, cabarmidomethylation of cysteine and phosphorylation of serine and threonine.
Recombinant protein production − cDNAs encoding StarD10 wild type, StarD10-S284A and StarD10-Δ8 were cloned into pGEX-6P (Amersham, Little Chalfont, UK) and transformed into BL21 bacteria to produce glutathione Stransferase (GST) fusion proteins. Expression was induced with 0.5 mM isopropyl-β-D-1-thiogalactopyranoside for 4 hrs at 30°C. Bacteria were harvested and resuspended in PBS containing 50 µg/ml lysozyme, Complete protease inhibitors, 10 mM sodium fluoride and 20 mM β-glycerophosphate. GST-StarD10 was purified from clarified lysate with glutathione resin and cleaved with PreScission protease according to the manufacturer's instructions (Amersham). The purity of protein preparations was verified by SDS-PAGE and Coomassie staining.
Cell fractionation and Western blotting − Cells were harvested in hypotonic buffer [20 mM Tris, pH 7.4, containing Complete protease inhibitors, 1 mM sodium orthovanadate, 5 mM β-glycerophosphate and 5 mM sodium fluoride] and sheared by passage through a 25G/16mm gauge needle. Nuclei were removed by centrifugation at 500xg and the cytosol (S) and membrane fraction (P) were obtained by 100.000xg centrifugation. 5% of the cytosol and 50% of the membrane fraction were separated by SDS-PAGE and transferred to polyvinylidine difluoride membranes (Roth). Immunodetection of StarD10 was performed by blocking membranes with 0.5% blocking reagent (Roche) in PBS containing 0.1% Tween 20, followed by incubation with Flag-, transferrin receptorand tubulin-specific antibodies in blocking buffer. Proteins were visualized with peroxidase-coupled secondary antibody using the enhanced chemiluminescence detection system (Pierce).
Immunoprecipitation and kinase assays − Cells were lysed in NEB (see above) and lysates were clarified by centrifugation at 16.000xg for 10 min. Equal amounts of protein were incubated with anti-Flag antibody for 2 h on ice. Immune complexes were collected with protein GSepharose (GE Healthcare), washed three times with NEB and twice with kinase buffer [50 mM Tris, pH 7.5, 10 mM MgCl 2 , 50 mM NaCl] before incubation with five units of calf intestinal phosphatase (Fermentas) for 45 min at 37°C. Dephosphorylated immunoprecipitates were again washed with NEB, followed by two washes with kinase buffer before incubation with 10 ng purified CKII (from B. Lüscher) in the presence of 25 µM cold ATP and 2 µCi [γ-32 P]-ATP for 30 min at 37 °C. Samples were resolved by SDS-PAGE, blotted onto membrane and analyzed on a PhosphoImager (Molecular Dynamics), followed by Western blotting with StarD10-specific antibody In the case of recombinant proteins used for lipid transfer assays, 40 µg protein was incubated with 500 Units CKII (Calbiochem) in kinase buffer [20 mM Tris, pH 7.5, 10 mM MgCl 2 , 50 mM KCl] in the presence of 200 µM ATP for 2 hours at 30°C.
Lipid transfer assays − HEK293T cells transiently expressing GFP-tagged StarD10 variants were harvested in hypotonic buffer (see above). The cytosol fraction was obtained after 100.000xg centrifugation for 1 h and the amount of expressed protein was quantified by measuring GFP peak emission at 480 -550 nm (excitation 466 nm). Protein-mediated transfer of PC between SUVs was measured as described previously (12) . The transfer assay mixture contained donor vesicles (1 µmol lipid/ml) composed of porcine brain lipids (Avanti Polar Lipids), pyrene-labeled PC and 2,4,6-trinitrophenylphosphatidylethanolamine (TNP-PE) (88.6:0.4:11 mol%), and a 10-fold excess of acceptor vesicles composed of porcine brain lipids. Fluorescence intensity was recorded at 395 nm (excitation, 345 nm; slit widths, 4 nm) before and after the addition of 90 µg cytosol from HEK293T cells transiently expressing the individual proteins (see above). Fluorescence intensities were normalized to (i) the maximum intensity obtained after the addition of Triton X-100 (0.5% final concentration) and (ii) the maximum GFP fluorescence, to account for different protein expression levels.
Membrane flotation assays − Multilamellar vesicles (MLVs) (concentration = 1 mM) were generated by resuspension of dried brain lipids in buffer [20 mM Hepes, pH 7.2, 5 mM EDTA, 100 mM NaCl]. MLVs (100 µl) were incubated with 50 µl recombinant StarD10 proteins (20 µg) for 10 min at 37°C. The suspension was adjusted to 30% (w/v) sucrose by addition of 100 µl 75% (w/v) sucrose, overlayed with 200 µl 25% (w/v) sucrose in buffer and 50 µl sucrose-free buffer. Samples were centrifuged at 240.000 x g for 1 h at 4°C in a TLS-55 rotor. The bottom (250 µl) and top (100 µl) fractions were collected and 5 µl aliquots were analyzed by immunoblotting.
RESULTS
Phosphorylation of human StarD10 on serine 284 − Phosphorylation of proteins is a common post-translational modification to regulate protein-protein interactions, protein localization or enzymatic activity by inducing conformational changes. We originally identified StarD10 as a phosphoprotein based on its crossreactivity with a phosphospecific antibody and mapped serine 259 to be phosphorylated and provide a specific antibody recognition site (14;16). When we further analyzed StarD10 by 2D-PAGE in lysates from HEK293T cells transiently expressing the protein, we noted three StarD10-specific spots of different pI values ( Figure 1A ). Such pI shifts are indicative of differential phosphorylation and suggested that at least one additional phosphorylation site existed in StarD10. To map potential phosphorylation sites in StarD10, we affinity-purified the protein and subjected it to analysis by tandem mass spectrometry.
Specific enrichment of phosphopetides was achieved by immobilized metal ion affinity chromatography with gallium(III) ions. The molecular mass of the [M+2H] 2+ -ion shown in Figure 1B corresponds Casein kinase II phosphorylates StarD10 on serine 284 − Serine 284 is located within an amino acid stretch containing several negatively charged residues, motifs that are typically recognized by casein kinase II, the minimal consensus sequence being S/T-X-X-D/E (see Figure 3A ). To investigate whether CKII was capable of phosphorylating StarD10 we first performed an in vitro kinase assay with recombinant StarD10 protein from E. coli that is not phosphorylated as determined by mass spetrometry (data not shown). Indeed, addition of purified CKII to the kinase reaction resulted in robust phosphorylation of StarD10 that was not seen in the absence of CKII (Figure 2, lanes 3&4 ). To analyze whether this phosphorylation occurred on serine 284, the wild type protein and a serineto-alanine exchange mutant were transiently expressed in HEK293T cells and immunoprecipitated from cell lysates. Incubation with CKII in the presence of radiolabeled ATP led to incorporation phosphate in the case of the wild type protein but was not seen for the mutant (Figure 2, lanes 1&2 ). This provides evidence that CKII is capable of phosphorylating StarD10 on a single residue, namely serine 284. The fact that CKII phosphorylation of StarD10 immunoprecipitated from cell lysates required prior protein dephosphorylation with alkaline phosphatase indicates a high stoichiometry of phosphorylation on serine 284.
Serine 284 phosphorylation regulates StarD10 lipid transfer activity − StarD10 functions as a lipid transfer protein specific for PC and PE. We therefore investigated whether StarD10 phosphorylation on serine 284 affected its phospholipid transfer activity. To this end, GFP fusions of StarD10 wild type and the S284A mutant were transiently expressed in HEK239T cells and the cytosol fraction was analyzed for PCspecific lipid transfer activity using a fluorescence resonance energy-based assay. Small unilamellar vesicles were prepared containing pyrene-labeled PC as a fluorescent donor and quenching amounts of head group-labeled TNP-PE (12;17). When these donor liposomes were mixed with an excess of unlabeled acceptor liposomes, the increase in pyrene fluorescence was negligible, indicating minimal spontaneous transfer (data not shown). Upon addition of StarD10-containing cytosol, a steady increase in fluorescence was noted compared to control cytosol of vector-transfected cells ( Figure 3B ). Compared to the wild type protein, cytosol containing StarD10-S284A promoted a more rapid increase in pyrene fluorescence. Interestingly, a truncated variant of StarD10 at residue 283, lacking the last 8 carboxyterminal amino acids (StarD10-Δ8; Figure  3A ), displayed even higher lipid transfer activity. Similar results were obtained with pyrene-labeled PE as a fluorescent donor (data not shown). Estimation of initial transfer rates revealed that the phosphorylation defective mutant was two-fold and the truncated protein 3.5-fold more active than the wild type protein ( Figure 3C ). These data suggest that StarD10 phosphorylation on serine 284 and the carboxyterminus in general inhibits StarD10 lipid transfer activity.
Regulation of lipid transfer by serine 284 phosphorylation does not require cellular cofactors − Serine/threonine phosphorylation often generates recognition sites for proteins containing specific phosphoserine-/threoninebinding domains and may thus be involved in protein complex formation. To address the question whether inhibition of StarD10 lipid transfer activity in response to CKII phosphorylation may be dependent upon cellular cofactors, we made use of recombinant StarD10 purified from E. coli, which is not posttranslationally modified. Recombinant StarD10 was incubated in kinase buffer containing ATP in the presence and absence of CKII. Phosphorylation of the protein on serine 284 was found to be highly efficient, as the unphosphorylated tryptic peptide was no longer detected by mass spectrometry (data not shown). When in vitro PC transfer of the phosphorylated protein was assessed, its activity was found to be diminished two-fold compared to that of the unphosphorylated protein (Figure 4 A&B) . CKII incubation of recombinant StarD10 in which serine 284 was exchanged to an alanine did not alter lipid transfer activity ( Figure 4B ), proving that inhibition of lipid transfer was indeed due to phosphorylation on this site. In accordance with the data obtained with StarD10 variants expressed in mammalian cells, the recombinant StarD10-Δ8 protein also displayed greater transfer activity. Taken together, these data provide evidence for a protein-intrinsic effect of phosphorylation on StarD10 activity.
The StarD10 carboxyterminus regulates membrane association − Enhanced lipid transfer activity of StarD10 variants lacking negative charge, either due to dephosphorylation or deletion of carboxyterminal acidic residues, could perhaps affect their affinity for membranes, facilitating lipid uptake from donor and release into acceptor membranes. To analyze whether the carboxyterminus of StarD10 is involved in membrane association, we generated multilamellar vesicles composed of porcine brain lipids and incubated these with recombinant StarD10 wild type and StarD10-Δ8 protein. MLV-associated protein was separated from unbound protein by sucrose gradient centrifugation and analyzed by immunoblotting. Compared to wild type StarD10, relatively more StarD10-Δ8 protein was recovered in the top MLV-containing fraction, suggesting increased affinity for membranes ( Figure 5A ). This finding was confirmed by fractionation of HEK293T transiently expressing StarD10 wild type, StarD10-S284A and StarD10-Δ8 variants ( Figure 5B ). Only a small proportion of the wild type protein was recovered in the pellet fraction whereas S284A and especially the truncated protein were enriched in this fraction. The purity of the individual fractions was confirmed by detection of the transferrin receptor in the membrane and tubulin in the cytosolic fraction ( Figure 5B ). Association with cellular membranes was further quantified by measuring GFP peak emission before and after 100.000xg centrifugation of cell lysates transiently expressing GFP fusions of StarD10 variants ( Figure 5C ). Thus, phosphorylation of StarD10 on serine 284 and the acidic carboxyterminus of StarD10 in general provide a mechanism by which membrane association is regulated.
DISCUSSION
Post-translational modification by phosphorylation is a common mechanism by which the activity of proteins can be regulated in a dynamic manner. Here we have mapped by mass spectrometry a novel in vivo phosphorylation site on serine 284 in StarD10 and provide evidence that phosphorylation on this site inhibits lipid transfer activity. Phosphorylation increases the local negative charge, eliciting conformational changes or influencing interaction with protein partners, or as shown here, with membranes. Simple exchange of serine 284 with glutamic acid, however, did not appear to mimic the phosphorylated state (data not shown). The carboxyterminus of StarD10 further comprises several acidic residues that apparently contribute to inhibition of membrane association. This is shown by deletion of the last eight carboxyterminal amino acids, which significantly increased membrane binding in vitro, association with cellular membranes in intact cells and, finally, in vitro lipid transfer activity.
It is conceivable that increased partitioning of StarD10 to membranes allows for fast and efficient lipid transfer by increasing the residence time of the protein at the membrane, thereby increasing the probability of lipid entry into (or exit from) the binding pocket. On the other hand, stable association with membranes could also inhibit lipid transfer, at least in vitro. In vivo, however, lipid transfer is thought to occur at membrane contact sites, at which membranes of two organelles come into close apposition (10) . Here, dissociation of the protein may not be a prerequisite for efficient lipid transfer.
We previously mapped serine 259 in StarD10 to be phosphorylated by a yet unknown kinase (16) . Based on results with a serine to alanine exchange mutant, phosphorylation on this site does not affect StarD10 lipid transfer activity (data not shown), but may rather determine protein stability as a StarD10-S259A mutant was repeatedly found to be expressed at lower levels. Of note, both phosphorylation sites operate independently from one another, since the StarD10-S284A mutant was still phosphorylated on serine 259 as determined by a phosphospecific antibody (data not shown).
Several members of the START family are known to be regulated by phosphorylation, either with regard to their activity or subcellular localization. In StAR, phosphorylation of serine 195 increases its steroidogenic activity in vivo as demonstrated by a phosphorylation site mutant (18) , whereas phosphorylation of Pctp regulates its relocation to mitochondria (19) . Inhibition of lipid transfer activity due to phosphorylation has been demonstrated for the ceramide transfer protein CERT. Phosphorylation by protein kinase D on serine 132 adjacent to the pleckstrin homology domain negatively regulates CERT interaction with phosphatidylinositol-4-phosphate and inhibits ceramide transfer activity (20) .
Although the cellular target membranes have yet to be identified, StarD10 transiently expressed in COS7 cells was found to be mainly cytosolic and it accumulated in a perinuclear region that may represent Golgi and ER membranes (data not shown). Correct localization likely involves association with protein partners and therefore attempts are being made to identify candidate proteins by yeast two hybrid screening.
Studies using truncation mutants and synthetic peptides have provided evidence that the carboxyterminus of Pctp may function as a membrane interaction domain involving an amphipathic α-helix. Removal of the last five residues of Pctp decreased its lipid transfer activity by 50%, whereas deletion of the last 10 residues completely abolished activity and markedly decreased the level of membrane binding (21) . Compared with Pctp, StarD10 has a 65 amino acid carboxyterminal extension, thus, deletion of the last eight residues leaves its START domain structurally intact and is not expected to impact on ligand binding. In line with this, lipid transfer activity of the StarD10-Δ8 mutant was found to be enhanced rather than abolished and was independent of cellular cofactors (Figure 4) . The carboxyterminal tail thus serves as an intrinsic regulator of StarD10 activity.
It appears that most of the StarD10 protein transiently expressed in HEK293T cells is phosphorylated on serine 284, because in vitro CKII phosphorylation required prior dephosphorylation of the protein. Similarly, PKCmediated phosphorylation of PITPβ isolated from brain could only be observed after dephosphorylation, indicating a high degree of phosphorylation (22) . In agreement with serine 284 phosphorylation inhibiting StarD10 membrane association, StarD10 expressed in cells was found to be mainly cytosolic ( Figure 5B&C ) and its lipid transfer activity was suppressed under normal growth conditions (Figure 3) . The challenge remains to identify those conditions that promote dephosphorylation of serine 284, either due to low CKII activity or activation of the phosphatase that dephosphorylates StarD10 on this site.
CKII is a ubiquitously expressed serine/threonine kinase with roles in proliferation, cell survival, differentiation, and transformation. CKII is a tetramer composed of two catalytic (α or α') and two regulatory β subunits. Initially thought to be constitutively active, it is now believed that different cellular CKII pools exist that are regulated locally by differential subunit assembly, phosphorylation, and association with scaffolding proteins (23;24) . High CKII levels are found in many proliferating tumors and in transgenic mice targeted expression of CKIIα in T cells and in the mammary gland induced lymphomagenesis and mammary tumorigenesis, respectively (25;26) . The potentiation of NF-κB and Wnt signaling pathways has been suggested to contribute to the oncogenic potential of CKII (25;26) . In addition, phoshorylation of proteins such as Bid and Max by CKII protects them from caspase-mediated cleavage, suggesting that CKII further enhances cancer cell survival by inhibiting the action of proteins involved in apoptosis (27;28) .
StarD10 was found to be overexpressed in Neu/ErbB2-induced mammary tumors in transgenic mice, in several human breast carcinoma cell lines and in 35% of primary human breast cancers (14) . In fibroblasts, StarD10 coexpression with the EGF receptor/ErbB1 augmented growth in soft agar, indicating that the presence of StarD10 may confer a growth advantage and contribute to cellular transformation (14) . Whether this is linked to its lipid transfer activity or may be due to an additional function is not known. Due to high CKII levels and/or activity in breast cancer cells, we assume that StarD10 is phosphorylated on serine 284 in these cells, downregulating membrane interaction and lipid transfer activity. In future studies it would thus be of interest to correlate the phosphorylation status of StarD10 with CKII activity in tumor cells. were obtained after 100.000xg centrifugation. Proteins were analyzed by immunoblotting with Flagspecific antibody, and transferrin receptor-and tubulin-specific antibodies to control the purity of the fractions. WB, Western blot. (C) HEK293T cells were transfected with expression plasmids encoding GFP-tagged StarD10 wild type (WT), StarD10-S284A and StarD10-Δ8, or GFP alone (con). Cells were lysed in hypotonic buffer and GFP peak fluorescence was determined before and after 100.000xg centrifugation and used to calculate the amount of GFP proteins in pellet fraction. Values are averages ± SD of two independent experiments. 
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